# Thoracoabdominal Arortic CTA Study

Study · id `cardio:ct-nct02291718` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02291718](<https://clinicaltrials.gov/study/NCT02291718>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT02291718

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT02291718. Non-randomized; no masking; primary purpose other. Start 2014-01 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2017-02-24.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose other
- Phase: Phase 4
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT02291718, source copy `cardio:ctgov-nct02291718-2017-04-18`, retrieved 2026-11-18)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT02291718, source copy `cardio:ctgov-nct02291718-2017-04-18`, retrieved 2026-11-18)
- Primary completion: 2015-09 (actual) (ClinicalTrials.gov record NCT02291718, source copy `cardio:ctgov-nct02291718-2017-04-18`, retrieved 2026-11-18)
- Completion: 2015-09 (actual) (ClinicalTrials.gov record NCT02291718, source copy `cardio:ctgov-nct02291718-2017-04-18`, retrieved 2026-11-18)
- Results first posted: 2017-02-24 (ClinicalTrials.gov record NCT02291718, source copy `cardio:ctgov-nct02291718-2017-04-18`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT02291718, source copy `cardio:ctgov-nct02291718-2017-04-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02291718-2017-04-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Thoracoabdominal Arortic CTA Study
- Condition: Thoracic Aortic Aneurysm
- Intervention (Drug): Isovue
- Lead sponsor: Duke University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Duke University (`cardio:org-duke-university`)

## Provenance

Content hash: d16ce7873a476b2134481d1011be04a2d0f728d421ec378b6a849c88f542da6f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
